HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

FLDK-P70

a standardized flavonoid extract from Diospyros kaki leaves with neuroprotective effects

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        FLDK-P70: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        FLDK-P70: 2

Experts

1.	Bei, Weijian: 2 articles (10/2009 - 03/2005)
2.	Peng, Wenlie: 2 articles (10/2009 - 03/2005)
3.	Xu, Anlong: 2 articles (10/2009 - 03/2005)
4.	Good, David A: 1 article (10/2009)
5.	Guo, Jiao: 1 article (10/2009)
6.	Hu, Dehui: 1 article (10/2009)
7.	Hu, Yinming: 1 article (10/2009)
8.	Li, Chuyuan: 1 article (10/2009)
9.	Wei, Ming: 1 article (10/2009)
10.	Wu, Wei: 1 article (10/2009)

Related Diseases

1.	Body Weight (Weight, Body) 10/29/2009 - "Similarly, administration of FLDK-P70 for 7 days (40, 80 mg/kg body weight, p.o., 3 days before and 4 days after MCAO) significantly reduced the lesion of the insulted brain hemisphere and improved the neurological behavior of rats. " 10/29/2009 - "Administration of FLDK-P70 for 12 days (40, 80 mg/kg body weight, p.o., 5 days before and 7 days after 4-VO) increased the survival of hippocampal CA1 pyramidal neurons after transient global brain ischemia. "
2.	Neurodegenerative Diseases (Neurodegenerative Disease) 10/29/2009 - "These results convincingly demonstrate that FLDK-P70 may be useful for the prevention and treatment of ischemia/reperfusion injury and other related neurodegenerative diseases." 03/11/2005 - "These results indicate that FLDK-P70 may be potentially used in the prevention and treatment of ischemia/reperfusion injury and other neurodegenerative disease. "
3.	Reperfusion Injury 10/29/2009 - "These results convincingly demonstrate that FLDK-P70 may be useful for the prevention and treatment of ischemia/reperfusion injury and other related neurodegenerative diseases." 03/11/2005 - "These results indicate that FLDK-P70 may be potentially used in the prevention and treatment of ischemia/reperfusion injury and other neurodegenerative disease. "
4.	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/29/2009 - "To investigate the neuroprotective effects of FLDK-P70, a standardized flavonoid extract, using in vivo rat models of both focal ischemia/reperfusion (I/R) injury induced by middle cerebral artery occlusion (MCAO) and on transient global brain ischemia induced by four-vessel occlusion (4-VO). "
5.	Ischemia 10/29/2009 - "To investigate the neuroprotective effects of FLDK-P70, a standardized flavonoid extract, using in vivo rat models of both focal ischemia/reperfusion (I/R) injury induced by middle cerebral artery occlusion (MCAO) and on transient global brain ischemia induced by four-vessel occlusion (4-VO). "

Related Drugs and Biologics

1.	Glutamic Acid (Glutamate)
2.	Neuroprotective Agents
3.	Flavonoids